Literature DB >> 30551537

Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.

Lei Wang1, Ling Ouyang2.   

Abstract

In order to investigate the role of EIF3B (eukaryotic translation initiation factor 3B, EIF3B) gene in the proliferation and apoptosis of ovarian cancer cells, a lentiviral vector system and shEIF3B lentiviral vector were constructed to transfect human ovarian cancer cells. SKOV3 and HO-8910 cells were used in this experiment. The cell growth was detected by Celigo cell counting assay, the apoptosis rate was measured by flow cytometry and the cell proliferation ability of lentivirus transfected cells was tested by MTT assay and clone formation assay. Results showed that the specific shRNA had a significant inhibitory effect on the expression of EIF3B gene. Compared with the negative control, the expression of EIF3B mRNA and protein in SKOV3 and HO-8910 cells were significantly inhibited in the knockdown group. Then the proliferation rate of each group was tested, we found that SKOV3 and HO-8910 cells in siRNA lentivirus infected group was significantly decreased. Same result was obtained from the clonogenic assay of which the colony formation of transfected cells was significantly inhibited compared with the control group. Further study showed that the proliferation inhibitory effect was associated with as increased apoptosis rate of SKOV3 and HO-8910 cells in EIF3B knockdown groups. All in all, inhibition of EIF3B gene expression significantly inhibit the proliferation of ovarian cancer cells and increase the apoptosis of ovarian cancer cells. These results provide a new basis for the study of the molecular mechanism of ovarian cancer development and provide new target gene for ovarian cancer treatment.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  EIF3B; Eukaryotic translation initiation factor; HO-8910; Ovarian cancer cell line SKOV3; Proliferation

Mesh:

Substances:

Year:  2018        PMID: 30551537     DOI: 10.1016/j.biopha.2018.10.027

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.

Authors:  Yonghuai Feng; Liusong Wu
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

2.  Knockdown of GBAS regulates esophageal cancer cell viability and apoptosis.

Authors:  Jun Peng; Ke Ma; Hao Rong; Bo Xiao; Jiang Zhu; Jin-Tao He
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

3.  SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.

Authors:  Tianshui Sun; Fangfang Bi; Zhuonan Liu; Qing Yang
Journal:  Aging (Albany NY)       Date:  2020-07-09       Impact factor: 5.682

4.  Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.

Authors:  Qing Yue; Lingyu Meng; Baoxing Jia; Wei Han
Journal:  Exp Ther Med       Date:  2020-05-07       Impact factor: 2.447

5.  Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.

Authors:  Nannan Zhao; Yanjuan Guo; Yanfang He; Yan Chen; Jun Xing
Journal:  J Clin Lab Anal       Date:  2020-05-17       Impact factor: 2.352

6.  Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.

Authors:  Shaoran Song; Jie Liu; Miao Zhang; Xiaoqian Gao; Wei Sun; Peijun Liu; Yaochun Wang; Juan Li
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.